Articles

Treatment of essential thrombocythemia in Europe: a prospective long-term observational study of 3649 high-risk patients in the Evaluation of Anagrelide Efficacy and Long-term Safety study

Department of Haematology, Institute for Medical Sciences, Uppsala University, Sweden
Department of Hematology, Hospital del Mar-IMIM, Barcelona, Spain
Hematology and Oncology, Johannes Wesling Medical Center, Minden, Germany
Department of Haematology, ‘L e A Seragnoli’, Sant’Orsola-Malpighi Hospital, Bologna, Italy
Department of Haematology, Guy’s and St Thomas’ NHS Foundation Trust, London, UK
Global Biometrics, Shire Pharmaceuticals, Lexington, MA, USA
Global Biometrics, Shire Pharmaceuticals, Lexington, MA, USA
Research & Development, Shire GmbH, Zug, Switzerland
APHP, Hopital Saint-Louis, Paris, France
Vol. 103 No. 1 (2018): January, 2018 https://doi.org/10.3324/haematol.2017.174672